JBCHEPHARM Statistics
Total Valuation
J. B. Chemicals & Pharmaceuticals has a market cap or net worth of INR 291.80 billion. The enterprise value is 290.98 billion.
Market Cap | 291.80B |
Enterprise Value | 290.98B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | Aug 14, 2024 |
Share Statistics
Shares Outstanding | n/a |
Shares Change (YoY) | +1.18% |
Shares Change (QoQ) | +1.23% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 71.17M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 49.56 |
EV / Sales | 8.10 |
EV / EBITDA | 31.14 |
EV / EBIT | 36.68 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.13 |
Debt / EBITDA | 0.40 |
Debt / FCF | n/a |
Interest Coverage | 21.31 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 15.61% |
Revenue Per Employee | 6.76M |
Profits Per Employee | 1.11M |
Employee Count | 5,311 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.25% in the last 52 weeks. The beta is -0.04, so J. B. Chemicals & Pharmaceuticals's price volatility has been lower than the market average.
Beta (5Y) | -0.04 |
52-Week Price Change | +35.25% |
50-Day Moving Average | 1,884.72 |
200-Day Moving Average | 1,791.20 |
Relative Strength Index (RSI) | 62.06 |
Average Volume (20 Days) | 238,648 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, J. B. Chemicals & Pharmaceuticals had revenue of INR 35.92 billion and earned 5.87 billion in profits. Earnings per share was 36.94.
Revenue | 35.92B |
Gross Profit | 23.48B |
Operating Income | 7.93B |
Pretax Income | 7.97B |
Net Income | 5.87B |
EBITDA | 9.34B |
EBIT | 7.93B |
Earnings Per Share (EPS) | 36.94 |
Balance Sheet
The company has 4.60 billion in cash and 3.78 billion in debt, giving a net cash position of 819.79 million.
Cash & Cash Equivalents | 4.60B |
Total Debt | 3.78B |
Net Cash | 819.79M |
Net Cash Per Share | n/a |
Equity (Book Value) | 29.23B |
Book Value Per Share | 188.37 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 65.37%, with operating and profit margins of 22.08% and 16.34%.
Gross Margin | 65.37% |
Operating Margin | 22.08% |
Pretax Margin | 22.19% |
Profit Margin | 16.34% |
EBITDA Margin | 26.01% |
EBIT Margin | 22.08% |
FCF Margin | n/a |
Dividends & Yields
J. B. Chemicals & Pharmaceuticals does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | 38.03% |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -1.18% |
Shareholder Yield | -1.18% |
Earnings Yield | 1.96% |
FCF Yield | n/a |
Stock Splits
The last stock split was on September 18, 2023. It was a forward split with a ratio of 2.
Last Split Date | Sep 18, 2023 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |